featured
PF-05280014 + Paclitaxel Is Equivalent to Reference Trastuzumab + Paclitaxel for HER2+ MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PF-05280014 (a Trastuzumab Biosimilar) Plus Paclitaxel Compared With Reference Trastuzumab Plus Paclitaxel for HER2-Positive Metastatic Breast Cancer: A Randomised, Double-Blind Study
Br. J. Cancer 2018 Dec 20;[EPub Ahead of Print], MD Pegram, I Bondarenko, MMC Zorzetto, S Hingmire, H Iwase, PV Krivorotko, KS Lee, RK Li, J Pikiel, R Aggarwal, R Ewesuedo, A Freyman, R Li, A Vana, D Yin, C Zacharchuk, E Tan-ChiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.